[1]
Al-rawaq, A., Neamah, N. and Alhamza, A. 2026. Asprosin as a novel biomarker for predicting diabetes mellitus risk in humans. Tropical Journal of Pharmaceutical Research. 25, 2 (Mar. 2026), 155–160. DOI:https://doi.org/10.4314/tjpr.v25i2.2.